Lessons from KEEPS: the Kronos Early Estrogen Prevention Study

References

• Writing Group for the Women’s Health Initiative randomized controlled trial. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002;288:321–33
   PubMed Web of Science ®Google Scholar
• Harman SM, Brinton EA, Cedars M, et al. KEEPS: the kronos early estrogen prevention study. Climacteric 2005;8:3–12
   PubMed Web of Science ®Google Scholar
• Anderson G, Cummings S, Freedman LS, et al. Design of the Women’s Health Initiative clinical trial and observational study. Controlled Clin Trials 1998;19:61–109
   PubMedGoogle Scholar
• Tan O, Harman S, Naftolin F. What we can learn from design faults in the Women’s Health Initiative randomized clinical trial? Bull NYU Hosp JT Dis 2009;67:226–9
   PubMedGoogle Scholar
• Miller VM, Black DM, Brinton EA, et al. Using basic science to design a clinical trial: Baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS). J Cardiovasc Transl Res 2009;2:228–39
   PubMed Web of Science ®Google Scholar
• Langer RD. The evidence base for HRT: what can we believe? Climacteric 2017;20:91–6
   PubMed Web of Science ®Google Scholar
• Harman SM, Black DM, Naftolin F, et al. Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial. Ann Intern Med 2014;161:249–60
   PubMed Web of Science ®Google Scholar
• Miller VM, Naftolin F, Asthana S, et al. The Kronos Early Estrogen Prevention Study (KEEPS): what have we learned? Menopause 2019;26:1071–84
   PubMed Web of Science ®Google Scholar
• Miller VM, Petterson TM, Jeavons EN, et al. Genetic polymorphisms associated with carotid artery intima-media thickness and coronary artery calcification in women of the Kronos Early Estrogen Prevention Study. Physiol Genomics 2013;45:79–88
   PubMed Web of Science ®Google Scholar
• Moyer AM, de Andrade M, Weinshilboum RM, Miller VM. Influence of SULT1A1 genetic variation on age at menopause, estrogen levels, and response to hormone therapy in recently postmenopausal white women. Menopause 2016;23:863–9
   PubMed Web of Science ®Google Scholar
• Hodis HN, Mack WJ, Henderson VW, et al. Vascular effects of early versus late postmenopausal treatment with estradiol. N Engl J Med 2016;374:1221–31
   PubMed Web of Science ®Google Scholar
• Miller VM, Jenkins GD, Biernacka JM, et al. Pharmacogenomics of estrogens on changes in carotid artery intima-medial thickness and coronary arterial calcification: Kronos Early Estrogen Prevention Study. Physiol Genomics 2016;48:33–41
   PubMed Web of Science ®Google Scholar
• Mason JC, Libby P. Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions. Eur Heart J 2015;36:482–9
   PubMed Web of Science ®Google Scholar
• Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature 2011;473:317–25
   PubMed Web of Science ®Google Scholar
• Naftolin F, Mehr H, Fadiel A. Sex steroids block the initiation of atherosclerosis. Reprod Sci 2016;23:1620–5
   PubMed Web of Science ®Google Scholar
• Miller VM, Lahr BD, Bailey KR, Hodis HN, Mulvagh SL, Jayachandran M. Specific cell-derived microvesicles: linking endothelial function to carotid artery intima-media thickness in low cardiovascular risk menopausal women. Atherosclerosis 2016;246:21–8
   PubMed Web of Science ®Google Scholar
• Jayachandran M, Garovic VD, Mielke MM, Bailey KR, Lahr BD, Miller VM. Characterization of intravascular cellular activation in relationship to subclinical atherosclerosis in postmenopausal women. PLoS One 2017;12:e0183159
   PubMed Web of Science ®Google Scholar
• Raz L, Hunter LW, Jayachandran M, Heit JA, Miller VM. Differential effects of oral and transdermal menopausal hormone therapy on prostacyclin and thromboxane in platelets. Physiol Rep 2014;2:e00275
   PubMedGoogle Scholar
• Hsia J, Langer RD, Manson JE, et al. Conjugated equine estrogens and coronary heart disease: the Women’s Health Initiative. Arch Intern Med 2006;166:357–65.
   PubMed Web of Science ®Google Scholar
• Manson J, Allison M, Rossouw JE, et al. Estrogen therapy and coronary-artery calcification. N Engl J Med 2007;356:2591–602
   PubMed Web of Science ®Google Scholar
• Harman SM, Vittinghoff E, Brinton EA, et al. Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes. Am J Med 2011;124:199–205
   PubMed Web of Science ®Google Scholar
• Wharton W, Gleason CE, Miller VM, Asthana S. Rationale and design of the Kronos Early Estrogen Prevention Study (KEEPS) and the KEEPS cognitive and affective sub study (KEEPS Cog). Brain Res 2013;1514:12–17
   PubMed Web of Science ®Google Scholar
• Papademetriou V. Hypertension and cognitive function. Blood pressure regulation and cognitive function: a review of the literature. Geriatrics 2005;60:20–2
   PubMed Web of Science ®Google Scholar
• Wharton W, Gleason CE, Dowling NM, et al. The KEEPS-cognitive and affective study: baseline associations between vascular risk factors and cognition. J Alzheimers Dis 2014;40:331–41
   PubMed Web of Science ®Google Scholar
• Gleason CE, Dowling NM, Wharton W, et al. Effects of hormone therapy on cognition and mood in recently postmenopausal women: findings from the randomized, controlled KEEPS-cognitive and affective study. PLoS Med 2015;12:e1001833
   PubMed Web of Science ®Google Scholar
• Santoro N, Allshouse A, Neal-Perry G, et al. Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: The Kronos Early Estrogen Prevention Study. Menopause 2017;24:238–46
   PubMed Web of Science ®Google Scholar
• Cintron D, Lahr BD, Bailey KR, et al. Effects of oral versus transdermal menopausal hormone treatments on self-reported sleep domains and their association with vasomotor symptoms in recently menopausal women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS). Menopause 2018;25:145–53
   PubMed Web of Science ®Google Scholar
• Raz L, Hunter LV, Dowling NM, et al. Differential effects of hormone therapy on serotonin, vascular function and mood in the KEEPS. Climacteric 2016;19:49–59
   PubMed Web of Science ®Google Scholar
• Moyer AM, de Andrade M, Faubion SS, et al. SLCO1B1 genetic variation and hormone therapy in menopausal women. Menopause 2018;25:877–82
   PubMed Web of Science ®Google Scholar
• Kling JM, Dowling NM, Bimonte-Nelson HA, et al. Impact of menopausal hormone formulations on pituitary-ovarian regulatory feedback. Am J Physiol Regul Integr Comp Physiol 2019;317:R912–R20
   PubMed Web of Science ®Google Scholar
• Lizneva D, Rahimova A, Kim SM, et al. FSH beyond fertility. Front Endocrinol (Lausanne) 2019;10:136
   PubMed Web of Science ®Google Scholar
• Naftolin F, Silva I, Orley A, Reproductive hormones and dementia. In: Schenker JG, Sciarra JJ, Mettler L, Genazzani AR, Birkhauser M, eds. Reproductive Medicine for Clinical Practice. Cham Switzerland: Springer; 2018:191–201
   Google Scholar
• Kantarci K, Lowe VJ, Lesnick TG, et al. Early postmenopausal transdermal 17β-Estradiol Therapy and Amyloid-β Deposition. J Alzheimers Dis 2016;53:547–56
   PubMed Web of Science ®Google Scholar
• Zeydan B, Lowe VJ, Tosakulwong N, et al. Sleep quality and beta-amyloid deposition in recently menopausal women participating in the Kronos Early estrogen Prevention Study (KEEPS). Alzheimer’s & Dementia 2019;15:P551–P551
   Google Scholar
• Barnes JN, Harvey RE, Zuk SM, et al. Aortic hemodynamics and white matter hyperintensities in normotensive postmenopausal women. J Neurol 2017;264:938–45
   PubMed Web of Science ®Google Scholar
• Harvey RE, Johnson MC, Ranadive SM, et al. Aortic hemodynamics in postmenopausal women following cessation of hormone therapy. Physiol Rep 2017;5:e13535
   Web of Science ®Google Scholar
• Raz L, Jayachandran M, Tosakulwong N, et al. Thrombogenic microvesicles and white matter hyperintensities in postmenopausal women. Neurology 2013;80:911–18
   PubMed Web of Science ®Google Scholar
• Jayachandran M, Lahr BD, Bailey KR, Miller VM, Kantarci K. Menopausal hormone therapy, blood thrombogenicity, and development of white matter hyperintensities in women of the Kronos Early Estrogen Prevention Study. Menopause 2020;27:305–10
   PubMed Web of Science ®Google Scholar
• Bush TL, Barrett-Connor E. Noncontraceptive estrogen use and cardiovascular disease. Epidemiol Rev 1985;7:89–104
   PubMed Web of Science ®Google Scholar
• Bush TL, Cowan LD, Barrett-Connor E, et al. Estrogen use and all-cause mortality. Preliminary results from the Lipid Research Clinics Program Follow-Up Study. JAMA 1983;249:903–6
   PubMed Web of Science ®Google Scholar
• Hodis H, Mack W, Lobo R, et al. Estrogen in the prevention of atherosclerosis. a randomized, double-blind, placebo-controlled trial. Ann Intern Med 2001;135:939–53
   PubMed Web of Science ®Google Scholar
• El Khoudary SR, Venugopal V, Manson JE, et al. Effects of hormone therapy on heart fat and atherosclerosis progression in recently postmenopausal women from the KEEPS Trial. Menopause 2020;27:255–62
   PubMed Web of Science ®Google Scholar
• El Khoudary SR, Zhao Q, Venugopal V, et al. Effects of hormone therapy on heart fat and coronary artery calcification progression: secondary analysis From the KEEPS Trial. J Am Heart Assoc 2019;8:e012763
   PubMed Web of Science ®Google Scholar
• Bush TL, Wells HB, James MK, et al. Effects of hormone therapy on bone mineral density – Results from the postmenopausal estrogen/progestin interventions (PEPI) trial. JAMA 1996;276:1389–96
   PubMed Web of Science ®Google Scholar
• Farr JN, Khosla S, Miyabara Y, Miller VM, Kearns AE. Effects of estrogen with micronized progesterone on cortical and trabecular bone mass and microstructure in recently postmenopausal women. J Clin Endocrinol Metab 2013;98:E249–57
   PubMed Web of Science ®Google Scholar
• Miyabara Y, Camp J, Holmes D, et al. Coronary arterial calcification and thoracic spine mineral density in early menopause. Climacteric 2011;14:438–44
   PubMed Web of Science ®Google Scholar
• Rosen R, Brown C, Heiman J, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000;26:191–208
   PubMed Web of Science ®Google Scholar
• Taylor HS, Tal A, Pal L, et al. Effects of oral vs transdermal estrogen therapy on sexual function in early postmenopause: ancillary study of the Kronos Early Estrogen Prevention Study (KEEPS). JAMA Intern Med 2017;177:1471–9
   PubMed Web of Science ®Google Scholar
• Chen GD, Oliver RH, Leung BS, Lin LY, Yeh J. Estrogen receptor alpha and beta expression in the vaginal walls and uterosacral ligaments of premenopausal and postmenopausal women. Fertil Steril 1999;71:1099–102
   PubMed Web of Science ®Google Scholar
• Fuermetz A, Schoenfeld M, Ennemoser S, Muetzel E, Jeschke U, Jundt K. Change of steroid receptor expression in the posterior vaginal wall after local estrogen therapy. Eur J Obstet Gynecol Reprod Biol 2015;187:45–50
   PubMed Web of Science ®Google Scholar
• Xie Z, Shi H, Zhou C, Dong M, Hong L, Jin H. Alterations of estrogen receptor-alpha and -beta in the anterior vaginal wall of women with urinary incontinence. Eur J Obstet Gynecol Reprod Biol 2007;134:254–8
   PubMed Web of Science ®Google Scholar